COVID-19 *CME

January 12, 2021

Perspectives on Use of the COVID-19 Vaccines and Psoriatic Disease (CME)

Episode 110

A discussion with NPF COVID-19 Task Force co-chairs dermatologist Dr. Joel Gelfand and rheumatologist Dr. Christopher Ritchlin with guest host Dr. Stacie Bell Chief Scientific and Medical Officer at the National Psoriasis Foundation.

COVID-19 Task Force co-chairs dermatologist Dr. Joel Gelfand, Psoriasis & Phototherapy Treatment Center at Penn, and rheumatologist Dr. Christopher Ritchlin, Psoriasis Center, University of Rochester Medical Center, return to discuss the new vaccines and their use with psoriatic disease treatments. 

For disclosures and credit, visit this page.

This program is supported by educational grants from Lilly, Bristol Myers Squibb and Novartis.

Share
Related Items

Stay in the Know.

Expert tips, can’t-miss events and the latest news, straight to your inbox.

National Health Council Standards of ExcellenceCharity NavigatorMy Psoriasis Team logo

Copyright © 1996-2021 National Psoriasis Foundation/USA


Duplication, rebroadcast, republication or other use of content appearing on this website is prohibited without written permission of the National Psoriasis Foundation (NPF).


NPF does not endorse or accept any responsibility for the content of external websites.


NPF does not endorse any specific treatments or medications for psoriasis and psoriatic arthritis.

We use cookies to offer you a better experience and analyze our site traffic. By continuing to use this website, you consent to the use of cookies in accordance with our Privacy Policy.